Mikhail Shchepinov -- Heavy Water Nutrients

![](0logo.gif)  
**[rexresearch.com](../index.htm)**

---

**Mikhail SHCHEPINOV**

**Deuterated Nutrients**

---

**<http://www.telegraph.co.uk/scienceandtechnology/science/sciencenews/3529878/Heavy-water-could-help-us-live-longer.html>**  
( 27 Nov 2008 )

**'Heavy Water' Could Help Us Live Longer**

*Drinking "heavy water" enriched with a rare form of hydrogen
could prolong our lives by up to ten years, it has been
claimed.*

By **Matthew Moore**

Mikhail Shchepinov, a former Oxford University scientist, says
that the modified drink protects against dangerous chemicals
known as free radicals that are known to contribute to
conditions such as cancer, Alzheimer's and Parkinson's.

He also claims that foods such as steak and eggs could be
enriched with the special hydrogen isotope, known as deuterium,
raising the possibility of people being able to "eat themselves
healthy".

His research has shown that worms live 10 per cent longer and
fruitflies up to 30 per cent longer when fed on heavy water,
which is slightly sweeter than normal water.

Dr Shchepinov, who runs the biotech firm Retrotope, now wants
to test his technology in pet foods, and believes that it could
one day be introduced to the food chain to allow humans to enjoy
its benefits without taking supplements.

"We don't have to be consuming isotopes as white powder. If you
take a pig and feed these things to a pig, all you need to do is
consume the pig in a normal fashion," he has said.

But other scientists have warned that Dr Shchepinov's theories
are far from proven. Tom Kirkwood, of Newcastle University, told
the Daily Mail: "Shchepinov's idea is interesting but . . . the
history in the field is cluttered with hypotheses which are only
partially supported by the data."

---

**<http://www.dailymail.co.uk/sciencetech/article-1089710/Its-time-raise-glass-heavy-water-longer-life.html>**  
( 27 November 2008 )

**It's time to raise a glass (of heavy
water) to a longer life**

**by**

**Fiona Macrae**

For centuries mankind has sought the secret of a long and
healthy life.

And for centuries it seems we were looking in the wrong place.
Forget exotic pills and potions, the key to prolonged life could
be as simple as a glass of water. Scientists believe 'heavy
water' enriched with a rare form of hydrogen could add as much
as ten years to life.

And by also modifying foods, such as steak and eggs, with the
hydrogen the way could be cleared to allowing us to eat and
drink our way to a healthy old age.

The idea is the brainchild of Mikhail Shchepinov, a former
Oxford University scientist.

It centres on fortifying the body's tissues and cells against
attack and decay caused by free radicals, dangerous chemicals
produced when food is turned into energy. Such 'attacks' on
proteins are particularly damaging and have been linked to
cancer, Alzheimer's and Parkinson's.

Dr Shchepinov's theory is based on deuterium, a
naturally-occurring isotope, or form of hydrogen, that
strengthens the bonds in between and around the body's cells,
making them less vulnerable to attack.

He found that water enriched with deuterium, which is twice as
heavy as normal hydrogen, extends the lifespan of worms by 10
per cent. And fruitflies fed the 'water of life' lived up to 30
per cent longer.

He now believes people could also benefit from the
sweet-tasting water, or from deuterium-enriched 'heavy foods'.

Foods could be created by either directly supplementing them
with deuterium or by enriching the feed of farm animals, this
week's New Scientist reports. Dr Shchepinov said recently: 'We
don't have to be consuming isotopes as white powder.

If you take a pig and feed these things to a pig, all you need
to do is consume the pig in normal fashion.'

The technology was likely to be tested in pet food first, he
added. Dr Shchepinov runs biotech firm Retrotope whose
scientific advisers include Aubrey de Grey, a controversial
ageing guru.

Dr de Grey, a 'bio-gerontologist' who leads the Methuselah
Foundation, a charity which aims for 'the defeat of age-related
disease and the indefinite extension of the healthy human
lifespan', said the research was 'extremely promising'.

He said deuterium existed in all living matter at a certain
level and it was a case of introducing it in a 'more targeted
manner'. There was no radiation involved, he added.

Dr Judith Campisi, of the Buck Institute for Age Research in
California, said: 'I've heard some pretty crazy ideas about how
we might live longer but I'm intrigued by this.'

But Tom Kirkwood, of Newcastle University, said: 'Shchepinov's
idea is interesting but . . . the history in the field is
cluttered with hypotheses which are only partially supported by
the data.'

---

**<http://www.newscientist.com/article/mg20026841.800-would-eating-heavy-atoms-lengthen-our-lives.html?page=2>**

**Would Eating Heavy Atoms Lengthen
Our Lives?**

**by**

**Graham Lawton**

In a back room of New Scientist's offices in London, I sit down
at a table with the Russian biochemist Mikhail Shchepinov. In
front of us are two teaspoons and a brown glass bottle.
Shchepinov opens the bottle, pours out a teaspoon of clear
liquid and drinks it down. He smiles. It's my turn.

I put a spoonful of the liquid in my mouth and swallow. It
tastes slightly sweet, which is a surprise. I was expecting it
to be exactly like water since that, in fact, is what it is -
heavy water to be precise, chemical formula D2O. The D stands
for deuterium, an isotope of hydrogen with an atomic mass of 2
instead of 1. Deuterium is what puts the heavy in heavy water.
An ice cube made out of it would sink in normal water.

My sip of heavy water is the culmination of a long journey
trying to get to the bottom of a remarkable claim that
Shchepinov first made around 18 months ago. He believes he has
discovered an elixir of youth, a way to drink (or more likely
eat) your way to a longer life. You may think that makes
Shchepinov sound like a snake-oil salesman. I thought so too,
but the more I found out about his idea, the more it began to
make sense.

The story began two years ago, while Shchepinov was working at
a biotechology company in Oxford, UK, and using his spare time
to read up on the latest ideas about what causes us to age.

The most widely accepted idea is the free-radical theory. This
holds that our slide into decrepitude is the result of
irreversible damage to the biomolecules that make up our bodies.
The main agents of this destruction are oxygen free radicals,
aggressive chemical compounds that are an unavoidable by-product
of metabolism.

The reason oxygen radicals are so dangerous is that they have a
voracious appetite for electrons, which they rip out of anything
they can lay their hands on - water, proteins, fats, DNA -
leaving a trail of destruction in their wake. This damage
gradually builds up over a lifetime and eventually leads the
body's basic biochemical processes to fail.

One of the worst types of damage is something called protein
carbonylation, in which an oxygen radical attacks vulnerable
carbon-hydrogen bonds in a protein (see diagram). This has been
linked to many of the worst diseases of old age, including
Parkinson's, Alzheimer's, cancer, chronic renal failure and
diabetes (The EMBO Journal, vol 24, p 1311). Other important
targets of free-radical attack are DNA and the fatty acids in
cell membranes.

The human body produces legions of antioxidants, including
vitamins and enzymes, that quench free radicals before they can
do any harm. But over a lifetime these defence systems
eventually fall victim to oxidative attack too, leading to an
inevitable decline.

Many anti-ageing medications are based on supplementing the
body's own defences with antioxidant compounds such as vitamin C
and beta-carotene, though there is scant evidence that this does
any good (New Scientist, 5 August 2006, p 40).

Shchepinov realised there was another way to defeat free
radicals. While he was familiarising himself with research on
ageing, his day job involved a well-established - if slightly
obscure - bit of chemistry called the isotope effect. On
Christmas day 2006, it dawned on him that putting the two
together could lead to a new way of postponing the ravages of
time.

The basic concept of the isotope effect is that the presence of
heavy isotopes in a molecule can slow down its chemical
reactions. This is because heavy isotopes form stronger covalent
bonds than their lighter counterparts; for example, a
carbon-deuterium bond is stronger than a carbon-hydrogen bond.
While the effect applies to all heavy isotopes, including
carbon-13, nitrogen-15 and oxygen-18 (see chart), it is most
marked with deuterium as it is proportionally so much heavier
than hydrogen. Deuterated bonds can be up to 80 times stronger
than those containing hydrogen.

All of this is conventional chemistry: the isotope effect was
discovered back in the 1930s and its mechanism explained in the
1940s. The effect has a long pedigree as a research tool in
basic chemistry for probing the mechanisms of complex reactions.

Shchepinov, however, is the first researcher to link the effect
with ageing. It dawned on him that if ageing is caused by free
radicals trashing covalent bonds, and if those same bonds can be
strengthened using the isotope effect, why not use it to make
vulnerable biomolecules more resistant to attack? All you would
have to do is judiciously place deuterium or carbon-13 in the
bonds that are most vulnerable to attack, and chemistry should
take care of the rest.

In early 2007 Shchepinov wrote up his idea and submitted it to
a journal called Rejuvenation Research. Unbeknown to him, the
journal's editor is controversial gerontologist Aubrey de Grey
of the Methuselah Foundation in Lorton, Virginia, who is well
known for supporting ideas other gerontologists consider
outlandish. De Grey sent the paper out for review and eventually
accepted it (*Rejuvenation Research*, vol 10, p 47).

In the paper, Shchepinov points out that there is masses of
existing science backing up his ideas. Dozens of experiments
have proved that proteins, fatty acids and DNA can be helped to
resist oxidative damage using the isotope effect.

Shchepinov's paper brought the idea to a wider audience,
including successful biotechnology entrepreneurs Charles Cantor
and Robert Molinari. Impressed, they teamed up with Shchepinov
to set up a company called Retrotope, with de Grey as a
scientific advisor.

It was around this time that I first got in touch with
Shchepinov. I'd never heard of the isotope effect, and de Grey's
involvement made me cautious. But there was something in the
idea that intrigued me, and I kept on coming back to it.

There were obvious objections to the idea. For one, how do you
get the isotopes to exactly the sites where you want them? After
all, the human body contains trillions upon trillions of
chemical bonds, but relatively few are vulnerable to
free-radical damage. And what about safety - swallowing
mouthfuls of heavy isotopes surely can't be good for you, can
it? That, of course, is how I ended up sharing a teaspoon of
heavy water with Shchepinov.

Neither, it turns out, is a big problem. Some heavy isotopes
are radioactive so are obviously ruled out on safety grounds -
hydrogen-3 (tritium) and carbon-14, for example. Others, notably
deuterium and carbon-13, are just as stable as hydrogen and
carbon-12. Both occur in small amounts in nature and are a
natural component of some biomolecules in our bodies (see "Heavy
babies").

Deuterium and carbon-13 also appear to be essentially
non-toxic. Baby mice weaned on a highly enriched carbon-13 diet
are completely normal, even when 60 per cent of the carbon atoms
in their body are carbon-13. Deuterium also has a clean bill of
health as long as you don't go overboard. Decades of experiments
in which animals were fed heavy water suggest that up to a fifth
of the water in your body can be replaced with heavy water with
no ill effects.

Similar experiments have been done on humans, albeit with lower
levels of deuterium. One recent experiment kept humans on a
low-level heavy-water diet for 10 weeks, during which their
heavy-water levels were raised to around 2.5 per cent of body
water, with no adverse effects (Biochimica et Biophysica Acta,
vol 1760, p 730). The researchers also found that some deuterium
became incorporated into proteins.

Heavy water, however, isn't completely safe. In mammals, toxic
effects start to kick in around the 20 per cent mark, and at 35
per cent it is lethal. This is largely down to the isotope
effect itself: any protein in your body has the potential to
take up deuterium atoms from heavy water, and eventually this
radically alters your entire biochemistry. You'd have to drink a
vast amount to suffer any ill effects - my 5 millilitres did me
no harm whatsoever - but even so, Retrotope is not advocating
heavy water as an elixir of youth.

Instead, it wants to package up heavy isotopes in what
Shchepinov calls "iFood". This method has huge advantages, not
least because it allows the heavy isotopes to be targeted to the
most vulnerable carbon-hydrogen bonds. Of the 20 amino acids
used by humans, 10 cannot be made by the body and must be
present in the diet. That means if you supplement your diet with
essential amino acids that have already had their vulnerable
bonds strengthened, your body's proteins will have these
reinforced amino acids incorporated into them. Some of the
building blocks of fats and DNA can also only be acquired via
your diet, which means they too can be targeted using the iFood
approach.

**Enriched eggs**

What's more, this approach ought to be completely safe, says
Shchepinov. Deuterium atoms bound to carbon in amino acids are
"non-exchangeable" and so don't leak into body water.

Another possibility is to produce meat, eggs or milk enriched
with deuterium or carbon-13 by feeding deuterated water or
isotope-enriched amino acids to farm animals.

For now, though, iFood remains on the drawing board as nobody
manufactures the right compounds. To solve that problem,
Retrotope has signed up the Institute of Bio-organic Chemistry
in Moscow, Russia and Minsk State University in Belarus to make
customised amino acids and fatty acids. "There are a lot of good
isotope chemists in Russia," says Cantor.

Another hurdle Retrotope will have to overcome is cost. At
current prices, a litre of heavy water will set you back $300.
"Isotopes are expensive," says Shchepinov. "But there's no need
for them to be. Methods are there to extract them, but nobody
wants them." Unless demand rises, there is no incentive to
produce them in bulk, and this keeps the price high.

These obstacles haven't stopped Retrotope launching a research
programme to test Shchepinov's big idea. A team at the Institute
for the Biology of Ageing in Moscow recently fed various amounts
of heavy water to fruit flies to see if it had any effect on
longevity. Though large amounts were deadly, smaller quantities
increased lifespans by up to 30 per cent.

It's a promising start, but it's too early to say whether the
human lifespan can also be extended in this way, or how much
deuterium-enriched food you would have to eat to get a
beneficial effect.

"This is preliminary and needs to be reproduced under a variety
of conditions," says Shchepinov. "It's possible that the flies
don't like the diet, and what we're seeing is the effects of
caloric restriction [the only proven strategy for extending
lifespan in experimental animals]. We need to do a lot more
experiments. But still..."

Retrotope has signed up some heavyweight gerontologists to join
de Grey as scientific advisors, including Jan Vijg of the Albert
Einstein College Of Medicine in New York and Cynthia Kenyon of
the University of California, San Francisco. Kenyon recently
started work on Retrotope's second round of experiments, giving
a deuterium-enriched diet to nematode worms.

"It's a beautiful idea," says Vijg. "It gives us a serious
chance of retarding ageing." He cautions, however, that
Shchepinov's ideas hinge on free radicals being at the root of
ageing. While this is still the leading theory in the field,
many researchers argue that free-radical damage alone cannot
account for all the biological changes that happen as we get old
(Nature, vol 451, p 644).

All of which makes other mainstream researchers very sceptical.
"Shchepinov's idea is interesting, but we're discovering that it
only makes sense to think about ageing in terms of multiple
underlying causes," says Tom Kirkwood of the University of
Newcastle, UK. "The history in the field is cluttered with
hypotheses which are only partially supported by the data.
Therefore, it is very unlikely that his suggested mechanism will
prove to be more than a small part of the much bigger picture."

Others are more positive. "I've heard some pretty crazy ideas
about how we might live longer, but I'm intrigued by this one,"
says Judith Campisi of the Buck Institute for Age Research in
Novato, California and the Lawrence Berkeley National
Laboratory, who has no formal links to Retrotope. "It's very
original and novel."

While Retrotope is concentrating its efforts on ageing,
Shchepinov says there are other applications of the isotope
effect he'd like to explore. One is shielding long-term space
travellers from the effects of cosmic rays and other ionising
radiation, which cause damage much like ageing.

Oxidative attack on carbon-hydrogen bonds is a problem in many
other areas, from drug discovery to cancer, cosmetics chemistry
and electronics. If the ageing research doesn't work out,
Retrotope will try something else. "We need to sort out what
works and what doesn't, and what works well enough to be
commercially exploited," says Cantor. "But this is going to work
somewhere, because the basic science is sound."

Sound basic science, of course, doesn't mean that Shchepinov
really has cracked a problem that's been troubling humanity for
millennia. Realistically, it's much more likely his insight will
lead to a more prosaic application, such as stopping coloured
plastics from fading in sunlight. But until he's proved wrong,
I'll keep on hoping that I shared my sip of heavy water with a
scientist who will be remembered long after I'm forgotten.   
Heavy babies

The idea of using chemical isotopes to combat ageing may be
new, but nature may already be onto that strategy as a way of
protecting us against free-radical attack, thought to be a key
cause of ageing. Babies and mice are born with much more of the
isotope carbon-13 in their bodies than their mothers, and women
appear to become unusually depleted in carbon-13 around the time
they give birth. Both findings suggest that there is active
transfer of carbon-13 from mother to fetus.One possible reason
for this, suggests Mikhail Shchepinov, chief scientific officer
of the biotechnology company Retrotope, which is investigating
the use of isotopes to slow ageing, is that the growing fetus
selectively builds carbon-13 into its proteins, DNA and other
biomolecules to take advantage of the way that heavy isotopes
make these molecules more resistant to free-radical attack.It
would make good evolutionary sense, as many of the proteins and
DNA molecules formed early on have to last a lifetime. "Every
single atom in the DNA of the brain of a 100-year-old man is the
same atom as when he was 15 years old," says Shchepinov ( *BioEssays*,
vol 29, p 1247 ).

---



**WO2007102030**   
**ISOTOPICALLY MODIFIED COMPOUNDS AND THEIR USE AS FOOD
SUPPLEMENTS**

2008-11-19   
Classification:  - international:  A23L1/29; A23L1/30;
A23L1/305; A23L1/29; A23L1/30; A23L1/305   
**Abstract** ---  A nutrient composition comprises an
essential nutrient in which at least one exchangeable H atom is
2H and/or at least one C atom is  13C. The nutrient is thus
protected from, inter alia, reactive oxygen species.

![](fig1.jpg)

![](fig2.jpg)

![](fig3.jpg)

![](fig4.jpg)

---

   
**US2011082208****THERAPIES FOR CANCER USING ISOTOPICALLY SUBSTITUTED
LYSINE**

**BACKGROUND**  
  
[0002] Lysyl oxidases (LOX, LOXL, LOXL2, etc.; amine oxidase
family) are Cu-dependent enzymes that oxidize lysine into
allysine (a-aminoadipic-d-semialdehyde) [Kagan H M. et al., J.
Cell. Biochem. 2003; 88:660]. LOX have been implicated in
crosslink formation in stromal collagens and elastins. LOX are
elevated in hypoxic tumors and affect cell motility, tumor
development and progression of metastasis [Kirschmann D A. et
al., Cancer Res. 2002; 62:4478]. This elevation is
mechanistically important for breast cancer metastasis and
invasion as well as in other cancers including colon and
esophagus [Fong S F, et al. genes Chromosomes Cancer 2007;
6:644], and is based on the formation of Schiff-base linkages
(aldehyde+amine) or aldol condensation products
(aldehyde+aldehyde), allowing cancer cells to latch on to
other cells/tissues. There are other mechanisms of LOX
involvement into metastasis progressionfor example, the
recruitment of bone marrowderived cells [Erler J T et al.
Nature 2006; 440:1222-1226; Erler J T. et al., Cancer Res.
2006; 66:10238; Erler I T et al. Cancer Cell 2009; 15:35-44]
for a so-called premetastatic niche formation...  
  
[0005] A reaction important in metastatic development. It is
therefore desirable to reduce the activity of lysyl oxidase in
cancer. As with any cancer treatment, it is also desirable
that this does not completely block the enzyme activity, so as
to minimize the adverse effects of therapy on other aspects of
physiology.  
  
[0006] It is therefore desirable to reduce the activity of
extracellular LOX in cancer. Some current approaches involve
LOX inhibitors (e.g. ss-aminopropionitrile [Jackson L E. et
al., Biochem. Biophys. Res. Commun. 1991; 179:939]),
sequestration of Cu, and the use of antibodies [Erler J T et
al., Nature 2006; 440:1222]. As with any cancer treatment, it
is also desirable that this does not completely block the
enzyme activity, so as to minimize the adverse effects of
therapy on other aspects of physiology. For example,
inhibition of LOX is known to cause increased elasticity of
blood vessels etc., leading to aneurisms. Besides, these
methods are likely to be immunogenic, as well as bringing
further complications such as toxicity.  
  
[0007] It is known that the rate of some reactions breaking or
forming chemical bonds is affected by the nature of the
isotopes of the atoms, which the bond links. In general, bonds
terminating in a heavy isotope will be less liable to cleavage
than a bond terminating in a lighter isotope. Of particular
note is that bonds between hydrogen atoms and other atoms are
less liable to breakage if the hydrogen is <2>H rather
than <1>H. A similar effect is seen when comparing the
rate of cleavage of a bond between a carbon atom and another
atom, where bonds with <13>C are less liable to cleavage
than bonds with <12>C. This is known as the Kinetic
Isotope Effect, and is well described. Many isotopes are known
to show this effect, as is described in Isotope effects in
chemical reactions. (C. J. Collins, N. S. Bowman (eds.) 1970).
It is known that these effects are also manifest in
enzyme-catalyzed reactions, as described in. Isotope effects
on enzyme-catalyzed reactions (Cleland, W. W., M. H. O'Leary,
and D. B. Northrop (eds.) 1976).  
  
**SUMMARY**  
[0008] The KIE may be used to reduce the activity of lysyl
oxidase without blocking its activity. Embodiments of this
invention provide for 2,6-diamino-6,6-dideuterohexanoic acid;
2,6-diamino-5,5,6,6-tetradeuterohexanoic acid or their esters
or amides, and for the use of such compounds in a treatment
for a disease in which lysyl oxidase is important.  
  
[0009] Embodiments of the invention also provide for
administering supplementation by any compounds containing
higher than naturally occurring prevalences of isotopes that
yield stabilization of lysine via the kinetic isotope effect
via incorporation of the higher than naturally occurring heavy
isotope into the lysine-containing moieties in the body
according to the Formulae I, II, and III described below for
stabilized lysine...

  


---

  
**US2014142059****THERAPEUTIC SUBSTANCES THAT MODULATE GENOME METHYLATION**

Compounds containing nucleic acid bases or their precursors
modified by enrichment at specific sites with heavy stable
isotopes of elements naturally present at those sites in
minute amount are useful for the treatment of diseases
characterized by altered gene expression and altered pattern
of epigenomic control. These compounds, when used as nutrients
or in other medicinal application methods, can alter the DNA
methylation pattern in a simple way through the
well-understood mechanism of kinetic isotope effect (KIE).
This effect could also be useful for modifying methylation
kinetics in stem cell technology, cloning and as disease
therapeutics.

  


---

  
**ISOTOPICALLY MODIFIED COMPOUNDS AND THEIR USE AS FOOD
SUPPLEMENTS****US8906405**

A nutrient composition comprises an essential nutrient in
which at least one exchangeable H atom is <2>H and/or at
least one C atom is <13>C. The nutrient is thus
protected from,inter alia, reactive oxygen species.  
  
**FIELD OF THE INVENTION**  
The present invention related to isotopically modified
compounds and their use as food supplements.  
  
**BACKGROUND OF THE INVENTION**  
A currently accepted theory of ageing blames the irreversible
changes in cell machinery and reduced efficiency of metabolic
processes on the detrimental effects of free radicals and
other reactive oxygen species (ROS) or reactive nitrogen
species (RNS) which are normally present in the cell as part
of the respiratory process. ROS and RNS oxidize/nitrate DNA,
proteins, lipids and other cell components. Of these, protein
oxidation, which converts arginine, lysine, threonine,
thryptophan and proline into corresponding carbonyl compounds,
cannot be repaired by proteases after a certain threshold
number of amino acid residues have been oxidized.  
  
The damaged protein loses its catalytic or structural
activity, but proteases are unable to disintegrate heavily
carbonylised strands, so that the damaged species accumulate
and aggregate, clogging up cellular passages. This rust-like
process gradually wears down all cellular mechanisms, slowing
everything down and ultimately causing cellular death.  
  
Apart from ageing, many diseases such as Alzheimer's,
Parkinson's, dementia, cataract, arthritis, chronic renal
failure, acute repiratory syndrome, cystic fibrosis, diabetes,
psoriasis and sepsis, to give a few examples, are associated
with increased protein carbonylation. Typically, physiological
levels of protein carbonyls are at around 1 nmol/mg protein,
whereas pathological levels go to 8 nmol/mg and above.  
  
For the two molecules involved in the process of oxidative
damage of proteins, i.e. an oxidizer and its substrate, the
oxidizer has been the subject of many studies aiming at
neutralizing or removing it by means of increasing the number
of antioxidants (vitamins, glutathione, peptides or enzymes).
The substrate, e.g. amino acid (AA) residues which are
converted into carbonyls, has received less attention.  
  
One common feature of all the AA residues (except praline)
vulnerable to carbonylation is that they belong to the group
of essential AAs, which cannot be synthesized by vertebrata
and should be ingested, e.g. consumed with food. The group
includes phenylalanine, valine, tryptophan, threonine,
isoleucine, methionine, histidine, arginine, lysine and
leucine (arginine is essential for children of up to 5 years
of age).  
  
Oxidation of both Arg and Lys by ROS yields aminoadipic
semialdehyde and proceeds through sequential replacement of
?-hydrogens with hydroxyls. Oxidation of Lys, Arg, Trp, Thr,
Phe and His is shown in FIG. 1. Side-chains undergo the same
transformations if these AAs are part of
polypeptides/proteins. Other essential AAs undergoing
ROS-driven oxidation include Leu (to 5-hydroxyleucine), Val
(3-hydroxyvaline) and Ile (several products).  
  
Other types of oxidative damages affecting essential AAs
involve reactive nitrogen species (RNS). Examples are shown in
FIG. 2.  
  
Yet another process detrimental to proteins is a ROS-driven
peptide bond cleavage, which is preceded by oxygen free
radical-mediated protein oxidation. A hydrogen atom is
abstracted from a Ca, atom of the polypeptide chain, which
then leads to formation of an alkoxyl radical. This can lead
either to hydroxyl protein derivative, or to peptide bond
cleavage by (1) diamide or (2) a-amidation pathway. This is
illustrated in FIG. 3.  
  
Nucleic acids are not normally considered as essential
components of the diet, but are also damaged by ROS. An
example particularly important for the mitochondrial
functioning is the formation of 8-oxy-G, as illustrated in
FIG. 4. This leads to mutations in the mitochondrial genome,
which is not maintained and repaired as efficiently as the
nuclear genome, with detrimental consequences to the
efficiency of respiratory processes in the cell. Another cause
of degradation is radiation.  
  
The kinetic isotope effect is widely used when elucidating
mechanisms and rate-determining stages of chemical and
biochemical reactions. The rate of reaction involving
C<1>H bond cleavage is typically 5 to 10 times faster
than the corresponding C<2>H (<2>H=D=deuterium)
bond cleavage, due to the two-fold difference in the masses of
H and D isotopes. The difference in reaction rates is even
higher for tritium (<3>H or T) as it is 3 times heavier
than hydrogen, but that isotope is unstable. The second
component of the CH bond, the carbon atom, can also be
substituted for a heavier <13>C isotope, but the bond
cleavage rate decrease will be much smaller, since <13>C
is only a fraction heavier than <12>C. See Park et al.,
JACS (2006) 128: 1868-72.  
  
Oxidation reactions are a good example of the isotope effect,
as the hydrogen subtraction by an oxidizer is usually a
rate-limiting step of the process. Damgaard, Biochemistry
(1981) 20: 5662-69, illustrates this: the kinetic isotope
effect upon V/K for (1-R)[1-<2>H2] and
(1-R)[1-<3>H2] ethanol oxidation by liver alcohol
dehydrogenase (ADH) to acetaldehyde, measured at pH 6, was 3
(D(V/K)) and 6.5 (T(V/K)), decreasing to 1.5 and 2.5
respectively at pH 9. Lower than expected rates confirm the
discrete role of the non-ADH systems as alternative pathways.
In vivo experiments in perfused rat liver, as reported in
Lundquist et al, Pharm. & Tox. (1989) 65: 55-62, gave the
mean value of D(V/K) of 2.89. Therefore, in all cases the
oxidation of deuterated ethanol was substantially slowed down.  
  
Isotopically labelled material has been administered to
animals, and also to humans, for diagnostic purposes. Gregg et
al, Life Sciences (1973) 13: 755-82, discloses the
administration to weanling mice of a diet in which the
digestible carbon fraction contained 80 atom % <13>C.
The additive was <13>C-labelled acetic acid. Tissue
examination revealed no abnormalities clearly attributable to
the high isotopic enrichment.  
  
**SUMMARY OF THE INVENTION**  
The present invention is based on the realisation that
isotopic substitution can be used to synthesize a class of
compounds that, when ingested, result in the formation of
bodily constituents (e.g. proteins, nucleic acids, fats,
carbohydrates, etc) that are functionally equivalent to normal
bodily constituents but which have a greater resistance to
degradative/detrimental processes, e.g. those mediated by ROS
and RNS or radiation. Therefore, according to this invention,
a nutrient composition comprises a nutrient composition
comprising an essential nutrient in which at least one
exchangeable H atom is <2>H and/or at least one C atom
is <13>C.  
  
Compounds for use in the invention are identical to normal
nutrients or constituents of food except that they contain
stable isotopes which, when incorporated into bodily
constituents make such bodily constituents more resistant to
degradative processes than they would be otherwise. They
provide a method for protecting the preferred functionality of
natural biomolecules; the method comprises supply of a
compound in such a way that it becomes incorporated into
biomolecules and in so doing confers properties on the
biomolecule that protect against damaging or unwanted chemical
changes.  
  
Compounds for use in the invention may be chemically
synthesized and, when ingested by an organism, are metabolized
in a way that results in the incorporation of the compound
into a functional biomolecule; the incorporation of the
compound resulting in the biomolecule having a higher degree
of resistance to damaging molecular changes than would be the
case for the equivalent biomolecule that did not comprise the
compound. Such compounds may act as mimics of naturally
occurring precursor elements of biomolecules. They may mimic
an essential amino acid. The organism is typically a plant,
microbe, animal or human.  
  
A compound for use in the invention is typically not degraded
by enzymes of the P450 pathway. It can therefore accumulate in
a subject for which it is essential.  
  
**DESCRIPTION OF THE INVENTION**  
The present invention relates to the fact that essential
supplements may undergo irreversible chemical transformations
such as oxidation, nitration, etc, leading to the onset of
senescence or diseases. Essential food components cannot be
synthesised de novo by an organism, e.g. mammal, primate or
human, and therefore need to be supplied with the diet. For
the purposes of this specification, a nucleic acid is
essential, although it may be more properly be described as
conditionally essential. Conditionally essential nutrients
need to be supplied with the diet under certain circumstances.  
  
For humans, 10 amino acids are essential, i.e. Phe, Val, Trp,
Thr, Ile, Met, His, Leu, Lys and Arg (up to the age of five).
Purine and pyrimidine nucleosides are conditionally essential.
Essential fatty acids are ?-3 and ?-6, while monounsaturated
oleic acid is generally non-essential.  
  
According to this invention, the proposed undesired effects
such as ageing/diseases can be slowed down. The compounds
consumed should be modified to slow down the undesired
reactions, while still retaining their chemical identity. This
can be achieved in one embodiment by substituting hydrogen
atoms subjected to abstraction during oxidation/oxidative
substitution at the most reactive carbon sites, or the sites
known to undergo the ROS/RNS inflicted damage as illustrated
on FIGS. 1-4, with deuteriums, which due to the isotope effect
slow down the rate of reactions. Substituting carbons instead
of or in addition to H atom substitution may require a greater
degree of substitution since one does not add so much to the
reaction rate decrease (D is twice the weight of H, and
<13>C is less than 10% heavier than <12>C).  
  
Depending in part of the method of preparation, a compound for
use in the invention may comprise partial or total isotopic
substitution. For example, deuterium substitution may be only
at the one or two hydrogen atoms that are considered
chemically exchangable, e.g. at OH or CH2 adjacent to a
functional group. Total rather than partial <13>C
substitution may often be achieved more effectively.

  


---

  
**US2014147428****NEURODEGENERATIVE DISORDERS AND MUSCLE DISEASES
IMPLICATING PUFAS****BACKGROUND**

**[0002] 1. Field**  
[0003] Isotopically modified polyunsaturated fatty acids
(PUFAs) and other modified PUFAs for treating certain
diseases, particularly Alzheimer's Disease, Mild Cognitive
Impairment, Frontotemperal Dementia, Amyotrophic Lateral
Sclerosis and Multiple Sclerosis.  
  
**[0004] 2. Description of the Related Art**  
[0005] Oxidative damage is implicated in a wide variety of
diseases such as mitochondrial diseases, neurodegenerative
diseases, neurodegenerative muscle diseases, retinal diseases,
energy processing disorders, kidney diseases, hepatic
diseases, lipidemias, cardiac diseases, inflammation, and
genetic disorders. Specifically, such diseases include but are
not limited to Alzheimer's Disease (AD), Mild Cognitive
Impairment (MCI), and Frontotemperal Dementia (FD).  
  
[0006] While the number of diseases associated with oxidative
stress are numerous and diverse, it is well established that
oxidative stress is caused by disturbances to the normal redox
state within cells. An imbalance between routine production
and detoxification of reactive oxygen species (ROS) such as
peroxides and free radicals can result in oxidative damage to
cellular structures and machinery. Under normal conditions, a
potentially important source of ROSs in aerobic organisms is
the leakage of activated oxygen from mitochondria during
normal oxidative respiration. Additionally, it is known that
macrophages and enzymatic reactions also contribute to the
generation of ROSs within cells. Because cells and their
internal organelles are lipid membrane-bound, ROSs can readily
contact membrane constituents and cause lipid oxidation.
Ultimately, such oxidative damage can be relayed to other
biomolecules within the cell, such as DNA and proteins,
through direct and indirect contact with activated oxygen,
oxidized membrane constituents, or other oxidized cellular
components. Thus, one can readily envision how oxidative
damage may propagate throughout a cell give the mobility of
internal constituents and the interconnectedness of cellular
pathways.  
  
[0007] Lipid-forming fatty acids are well-known as one of the
major components of living cells. As such, they participate in
numerous metabolic pathways, and play an important role in a
variety of pathologies. Polyunsaturated Fatty Acids (PUFAs)
are an important sub-class of fatty acids. An essential
nutrient is a food component that directly, or via conversion,
serves an essential biological function and which is not
produced endogenously or in large enough amounts to cover the
requirements. For homeothermic animals, the two rigorously
essential PUFAs are linoleic (cis,cis-9,12-Octadecadienoic
acid; (9Z,12Z)-9,12-Octadecadienoic acid; LA; 18:2; n-6) and
alpha-linolenic (cis,cis,cis-9,12,15-Octadecatrienoic acid;
(9Z,12Z,15Z)-9,12,15-Octadecatrienoic acid; ALA; 18:3; n-3)
acids, formerly known as vitamin F (Cunnane S C. Progress in
Lipid Research 2003; 42:544-568). LA, by further enzymatic
desaturation and elongation, is converted into higher n-6
PUFAs such as arachidonic (AA; 20:4; n-6) acid; whereas ALA
gives rise to a higher n-3 series, including, but not limited
to, eicosapentaenoic acid (EPA; 20:5; n-3) and docosahexaenoic
(DHA; 22:6; n-3) acid (Goyens P L. et al. Am. J. Clin. Nutr.
2006; 84:44-53). Because of the essential nature of certain
PUFAs or PUFA precursors, there are many known instances of
their deficiency and these are often linked to medical
conditions. Furthermore, many PUFA supplements are available
over-the-counter, with proven efficiency against certain
ailments (See, for example, U.S. Pat. No. 7,271,315 and U.S.
Pat. No. 7,381,558).  
  
[0008] PUFAs endow mitochondrial membranes with appropriate
fluidity necessary for optimal oxidative phosphorylation
performance. PUFAs also play an important role in initiation
and propagation of the oxidative stress. PUFAs react with ROS
through a chain reaction that amplifies an original event (Sun
M, Salomon R G, J. Am. Chem. Soc. 2004; 126:5699-5708).
However, non-enzymatic formation of high levels of lipid
hydroperoxides is known to result in several detrimental
changes. Indeed, Coenzyme Q10 has been linked to increased
PUFA toxicity via PUFA peroxidation and the toxicity of the
resulting products (Do T Q et al, PNAS USA 1996;
93:7534-7539). Such oxidized products negatively affect the
fluidity and permeability of their membranes; they lead to
oxidation of membrane proteins; and they can be converted into
a large number of highly reactive carbonyl compounds. The
latter include reactive species such as acrolein, malonic
dialdehyde, glyoxal, methylglyoxal, etc. (Negre-Salvayre A, et
al. Brit. J. Pharmacol. 2008; 153:6-20). But the most
prominent products of PUFA oxidation are alpha,
beta-unsaturated aldehydes such as 4-hydroxynon-2-enal (4-HNE;
formed from n-6 PUFAs like LA or AA), 4-hydroxyhex-2-enal
(4-HHE; formed from n-3 PUFAs like ALA or DHA), and
corresponding ketoaldehydes (Esterfbauer H, et al. Free Rad.
Biol. Med. 1991; 11:81-128; Long E K, Picklo M J. Free Rad.
Biol. Med. 2010; 49:1-8). These reactive carbonyls cross-link
(bio)molecules through Michael addition or Schiff base
formation pathways, and have been implicated in a large number
of pathological processes (such as those introduced above),
age-related and oxidative stress-related conditions, and
aging. Importantly, in some cases, PUFAs appear to oxidize at
specific sites because methylene groups of 1,4-diene systems
(the bis-allylic position) are substantially less stable to
ROS, and to enzymes such as cyclogenases and lipoxygenases,
than allylic methylenes.  
  
[0009] We have now discovered that oxidation resistant PUFAs,
PUFA mimetics, PUFA pro-drugs and/or fats containing oxidation
resistant PUFAs and PUFA mimetics that are useful for treating
and/or inhibiting neurodegenerative disorders...

  

---